Back
Exagen, Inc. 10K Form
Sell
38
XGN
Exagen, Inc.
Last Price:
$7.48
Seasonality Move:
12.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-25 | 10K | XGN/Exagen, Inc. Annual |
| 2019-11-12 | 10Q | XGN/Exagen, Inc. Quarterly |
Receive XGN News And Ratings
See the #1 stock for the next 7 days that we like better than XGN
XGN Financial Statistics
Sales & Book Value
| Annual Sales: | $55.6M |
|---|---|
| Cash Flow: | $2.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.81 |
| Price / Book: | 9.1 |
Profitability
| EPS (TTM): | -0.92570 |
|---|---|
| Net Income (TTM): | $-19M |
| Gross Margin: | $33.1M |
| Return on Equity: | -140.03% |
| Return on Assets: | -37.95% |
Exagen, Inc. Earnings Forecast
Key Exagen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for XGN is 59.51%.
-
The Selling, General & Administrative Expenses for XGN have been equal to 74.36% of Gross Profit Margin.
-
The Research & Development expenses have been 9.66% of Revenue.
-
The Net Earning history of XGN is -27.17% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 5 years.
Exagen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XGN |
| Website: | exagen.com |
Debt
| Debt-to-Equity Ratio: | 1.55 |
|---|---|
| Current Ratio: | 4.08 |
| Quick Ratio: | 3.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XGN Technical Analysis vs Fundamental Analysis
Sell
38
Exagen, Inc. (XGN)
is a Sell
Is Exagen, Inc. a Buy or a Sell?
-
Exagen, Inc. stock is rated a SellThe current Exagen, Inc. [XGN] share price is $7.28. The Score for XGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.